Brief news reports on Tuberculosis

MSF: First-ever study of HIV treatment policies in 23 countries

The study looks at 25 indicators in each country, ranging from coverage of ART and prevention of mother-to-child transmission, to whether nurses instead of doctors can start patients on HIV and TB treatment.

Read More →

'Global health charge' on alcohol and tobacco could cover HIV drug costs in 10 countries

A modest increase in taxes on alcohol and tobacco in countries seriously affected by HIV and TB could generate enough income to cover the costs of antiretroviral treatment, TB treatment and malaria treatment and prevention, as well as reducing the incidence of non-communicable diseases caused by alcohol and tobacco, according to modelling work presented at the 19th International AIDS Conference (AIDS 2012) in Washington DC.

Read More →

Weekly rifapentine for 3 months safer than 9 months of INH in HIV+

Three months of once-weekly observed rifapentine plus isoniazid (3HP) proved safer and more tolerable than 9 months of daily self-administered isoniazid (9H) in HIV-positive people from North America, South America, and Spain. HIV-positive people were less likely to stop 3HP than HIV-negative people enrolled in the same trial, TBTC Study 26/ACTG 5259.

Read More →

Trial signals major milestone in hunt for new TB drugs

Lancet paper finds novel drug regimen could be more effective than existing treatments; TB Alliance’s trial to test drugs in combination saves years in research time.

Read More →

Researchers call for change in new FDA recommendation on HIV and TB drug doses

In January, 2012, the U.S. Food and Drug Administration (FDA) issued new guidelines on dosing of an HIV medication used to treat people infected with both HIV and tuberculosis (TB) because of a potential interaction between two of the main drugs used to treat each disease.

Read More →

TB response requires momentum of AIDS activism

Treatment Action Group’s leader Mark Harrington did not mince words Saturday at a consultation meeting on HIV and tuberculosis (TB) co-infection preceding the 2012 International AIDS Conference in Washington.

Read More →

“Asleep at the Wheel:” The early response to the twin epidemics TB-HIV

We often cite the fact that tuberculosis (TB) fueled the spread of HIV in southern Africa, said Diane Havlir, MD, of the University of California at San Francisco and co-Chair of the 2012 International AIDS Conference (IAC). But AIDS also shaped the enormous spread of TB seen in southern Africa during the late 80s and ’90s as a sweeping increase in HIV/AIDS occurred simultaneously, she said.

Read More →

TB REACH launches call for proposals for Wave 3

TB REACH, an initiative of the Stop TB Partnership to promote early and increased TB case detection, today has launched its call for applications for Wave 3 funding. Partners of the Stop TB Partnership, national TB programmes, HIV programmes, local and international NGOs, civil society and community-based organizations can apply for this fast-track funding for early and increased TB case detection among poor, vulnerable and at-risk populations.

Read More →

Pakistan: Making TB a notifiable disease

A new legislation is on the anvil to declare tuberculosis (TB) as a notifiable disease in Pakistan. When passed, the “Tuberculosis Notification Act, 2012” would make it mandatory on all registered medical and traditional practitioners, registered hakims, healthcare providers, pathological laboratories, educational institutions, industrial concerns, mines, jails, madrasas, refugee camps, councilors, tribal heads, maliks, lumbardars, appointed and hereditary community representatives to notify District EDO Health of a confirmed or suspected TB case in accordance with the set procedures.

Read More →

Addressing the challenges to transform the HIV-TB response

The dual HIV-TB epidemic has posed a challenge for both TB and HIV efforts at all levels. Although the number of people living with HIV (PLHIV) screened for TB increased almost 12-fold, (from nearly 200 000 to over 2.3 million people) and testing for HIV among TB patients increased 5-fold (from 470,000 to over 2.2 million) between 2005 and 2010, almost a quarter of all AIDS deaths every year are still caused by TB despite it being preventable. An estimated 910,000 lives were saved globally over the last six years through the implementation of collaborative TB/HIV activities, yet only 46% of TB patients living with HIV received ART in 2010. Not all people living with HIV who enrolled into care were screened for TB and a far smaller proportion received isoniazid preventive treatment (IPT). In many high burden countries there has been little progress in the implementation of collaborative TB/HIV activities. 

Read More →

Page 546 of 623 · Total posts: 10

←First 545 546 547 Last→